Solid dispersion-based pellet for colon delivery of tacrolimus through time- and pH-dependent layer coating: preparation, in vitro and in vivo studies

被引:3
作者
Guo, Jian [1 ,2 ]
Fang, Huihui [1 ]
Gui, Shuangying [1 ,3 ]
Huang, Yuzhe [1 ]
机构
[1] Anhui Univ Chinese Med, Coll Pharm, Dept Pharmaceut, 1 Qianjiang Rd, Hefei 230012, Anhui, Peoples R China
[2] Nanjing Univ Chinese Med, Affiliated Hosp Integrated Tradit Chinese & Weste, Nanjing, Jiangsu, Peoples R China
[3] Anhui Acad Chinese Med, Inst Pharmaceut, Hefei, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
Tacrolimus; Solid dispersion; Pellet; Oral colon-specific; Biodistribution; TARGETED DELIVERY; SUSTAINED-RELEASE; ORAL TACROLIMUS; PHARMACOKINETICS; FORMULATION; TABLETS; SYSTEM; FK506;
D O I
10.1590/s2175-97902019000217309
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The intent of the present investigation is to develop and evaluate colon-specific coated tacrolimus solid dispersion pellet (SDP) that retards drug release in the stomach and small intestine but progressively releases in the colon. Tacrolimus-SDP was prepared by extrusion-spheronization technology and optimized by the micromeritic properties including flowability, friability, yields and dissolution rate. Subsequently, the pH-dependent layer (Eudragit L30D55) and time-dependent layer (Eudragit NE30D and L30D55) were coated on the SDP to form tacrolimus colon-specific pellets (CSP) using a fluidized bed coater. Under in vitro gradient pH environment, tacrolimus only released from CSP after changing pH to 6.8 and then quickly released in the phosphate buffer solution of pH 7.2. The Cmax of CSP was 195.68 +/- 3.14 ng/mL at Tmax 4.5 +/- 0.24 h where as in case of SDP, the Cmax was 646.16 +/- 8.15 ng/mL at Tmax 0.5 +/- 0.03 h, indicating the ability of CSP targeted to colon. The highest area under the curve was achieved 2479.58 +/- 183.33 ng.h/mL for SDP, which was 2.27-fold higher than tacrolimus suspension. However, the best biodistribution performance was achieved from CSP. In conclusion, SDP combining of pH- and time-dependent approaches was suitable for targeted delivery of tacrolimus to colon.
引用
收藏
页数:14
相关论文
共 35 条
  • [1] Bansal Vipin, 2014, Polim Med, V44, P109
  • [2] Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - A long-term follow-up
    Baumgart, Daniel C.
    Pintoffl, Jan P.
    Sturm, Andreas
    Wiedenmann, Bertram
    Dignass, Axel U.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (05) : 1048 - 1056
  • [3] Baumgart DC, 2008, COCHRANE DB SYST REV, V16
  • [4] Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment
    Bose, A.
    Elyagoby, A.
    Wong, T. W.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) : 178 - 186
  • [5] De Toni L, 2015, GASTROENT RES PRACT, V2015
  • [6] Dhandapani NV, 2005, OPTICAL ENG, V44
  • [7] Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation
    Dodoo, Cornelius C.
    Wang, Jie
    Basit, Abdul W.
    Stapleton, Paul
    Gaisford, Simon
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2017, 530 (1-2) : 224 - 229
  • [8] Fang H, 2015, MOJ BIOEQUIVALENCE B, V1
  • [9] [方慧慧 Fang Huihui], 2016, [中国医院药学杂志, Chinese Journal of Hospital Pharmacy], V36, P710
  • [10] Preparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability
    He, Haibing
    Li, Hui
    Tang, Xing
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2011, 16 (03) : 212 - 218